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Nephrology consults increase
To the Editor: The article by Jain et al on ‘When laboratories
report estimated glomerular ﬁltration rates in addition to
serum creatinines, nephrology consults increase’’ deserves
further comment on both the cause and the magnitude of
increase in nephrology consultations.1
A more rigorous approach would have been to look at
secular trends in nephrology consults in other regions that
had not implemented routine estimated glomerular ﬁltration
rate (eGFR) reporting rather than using dermatology consults
as the comparator. Figure 1 shows the new outpatient
nephrology consults at Capital Health, Halifax, Nova Scotia,
over a similar time period. We provide nephrology consultant
service for a relatively stable catchment population of
approximately 700,000–800,000 people. Routine reporting or
at request eGFR had not been implemented in the province;
however, we experienced a similar increase in consultations
(27 vs. 24%) at a time similar to the introduction of eGFR in
Ontario. The absolute increase, relative to the catchment
population, is also comparable. The sudden increase at our
center was a response to growing referrals and a desire to
reduce wait times, implying that the stimulus was already in
place. The increase in demand also predated a reduction in
the upper limit of normal for serum creatinine for women by
the laboratory, which also appears to have increased the
referrals of older women.
Although analyses of administrative databases are conve-
nient they may not accurately assess the magnitude of
the impact. Nephrology consults underestimate actual and
potential referrals for several reasons. There may be an
increase in referrals to general internists for patients in
areas geographically remote, wait lists grow, and sometimes
we contact referring physicians by phone or letter instructing
investigation and treatment of less urgent cases, there-
by avoiding the need for a billed consult. Although
unsubstantiated, as wait lists grow some primary care
physicians simply forgo less urgent referrals. Finally, some
of the increase is not low eGFR. There are a small but growing
number of nondiabetic patients referred with isolated
microalbuminuria.
Reporting that labels someone as having an abnormal lab
test (eGFR or creatinine) results in referral without increasing
the knowledge of the primary care provider. We have recently
seen a decrease in nephrology consults and feel that this may
in part be the result of education targeted at the primary
practitioner on the evaluation and treatment of chronic
kidney disease. Now that Jain et al.1 have demonstrated
increase consult rates we must examine the impact on health
outcomes and costs for those now being referred. Given
staggering increases in health care expenditures we should
strive for the evidence that this increased referral (age 470
with eGFR between 45–60ml/min per 1.73m2) has measur-
able beneﬁt. As an example that the beneﬁts derived may be
limited in the older population, the US Preventive Services
Task Force now recommends against routine colorectal
screening in individuals475 years of age because of reduced
beneﬁts from competing risks of death.2 Electronic medical
records that incorporate decision layer support based on
eGFR and increased risk responsive to intervention would be
a useful next step.
1. Jain AK, McLeod I, Huo C et al. When laboratories report estimated
glomerular filtration rates in addition to serum creatinines, nephrology
consults increase. Kidney Int 2009; 76: 318–323.
2. Screening for Colorectal Cancer, March 2009. U.S. Preventive Services
Task Force. Agency for Healthcare Research and Quality: Rockville, MD.
http://www.ahrq.gov/clinic/uspstf/uspscolo.htm
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Where are cut-off values of
serum creatinine in the setting
of chronic kidney disease?
To the Editor: We read with interest the article ‘When
laboratories report estimated glomerular ﬁltration rates in
addition to serum creatinines, nephrology consults increase’
by Jain et al.1 However, we thought it would be fair for them
to give a chance for serum creatinine (Scr) levels to change
before they simply say that Scr may remain normal or only
mildly elevated in the setting of chronic kidney disease
(CKD).
The optimal cut-off values of Scr according to CKD stage
were calculated for 253 patients who were over 18 years of
age, using the receiver operating characteristic curves2 that
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Figure 1 |New nephrology consults.
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were formed by creatinine clearance measured from 24 h
urine (Table 1). For 13,905 patients who were over 18 years of
age, the number of patients from cut-off values of Scr and
estimated glomerular ﬁltration rate (eGFR) formula at each
CKD stage were compared. The four-variable Modiﬁcation of
Diet in Renal Disease Study equation using Japanese race
factor was applied for eGFR.3
The number of patients per CKD stage, which was
classiﬁed using the newly established Scr cut-off values,
showed very similar results to the number of patients
classiﬁed using eGFR cut-off values (Table 1). In conclusion,
setting the cut-off values would be necessary when applying
Scr to CKD.
1. Jain AK, McLeod I, Huo C et al. When laboratories report estimated
glomerular filtration rates in addition to serum creatinines, nephrology
consults increase. Kidney Int 2009; 76: 318–323.
2. Tripepi G, Jager KJ, Dekker FW et al. Diagnostic methods 2: receiver
operating characteristic (ROC) curves. Kidney Int 2009; 76: 252–256.
3. Imai E, Horio M, Nitta K et al. Estimation of glomerular filtration rate by the
MDRD study equation modified for Japanese patients with chronic kidney
disease. Clin Exp Nephrol 2007; 11: 41–50.
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Nephroprevention in acute
phosphate nephropathy
To the Editor: We read the article by Markowitz and
Perazella,1 who masterfully show us the actuality of acute
phosphate nephropathy, this is probably a not uncommon
cause of kidney injury.
Lien2 previously referred to possible strategies to prevent
the side effects of phosphate overload, so we could establish a
preventive strategy:
(1) Avoid use in high-risk patients.1,2 (2) Use the minimal
effective dose,3 the total amount of phosphate excreted in the
urine after the second dose is threefold to fourfold to that
excreted after the ﬁrst dose; this suggests that the second dose
is particularly dangerous,4 so a reduction or replacement with
another agent (magnesium citrate or low-volume polyethy-
lene glycol) would be possible. (3) Increase the interval bet-
ween doses; a 24 h interval reduces the incidence of clinically
relevant hyperphosphatemia, with no loss of efﬁcacy com-
pared with an interval of 9–12 h.3 (4) Avoid dehydration;1,2
clear ﬂuid should be administered; in some centers Gatorade
or E-lyte is recommended (possibly a superior alternative).
Furthermore, monitoring of body weight and urine color is
useful to guide ﬂuid intake. During the procedure an
intravenous line is routinely placed and normal saline could
be given during and after the procedure. (5) Perform serum
biochemistry tests before colonoscopy and measure the renal
function and baseline electrolytes; in high-risk or unstable
patients a control 2 or 3 days after would be necessary. (6)
Finally, consider an alternative bowel-cleansing agent.
1. Markowitz GS, Perazella MA. Acute phosphate nephropathy. Kidney Int
2009; 76: 1027–1034.
2. Lien YH. Is bowel preparation before colonoscopy a risky business for the
kidney? Nat Clin Pract Nephrol 2008; 4: 606–614.
3. Rostom A, Jolicoeur E, Dube C et al. A randomized prospective trial
comparing different regimens of oral sodium phosphate and polyethylene
glycol-based lavage solution in the preparation of patients for
colonoscopy. Gastrointest Endosc 2006; 64: 544–552.
4. Caswell M, Thompson WO, Kanapka JA et al. The time course and effect on
serum electrolytes of oral sodium phosphates solution in healthy male and
female volunteers. Can J Clin Pharmacol 2007; 14: e260–e274.
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Cognitive-behavioral group
therapy is an effective treatment
for major depression in
hemodialysis (HD) patients
To the Editor: We read with great interest the article by
Duarte et al.1 evaluating a randomized trial on cognitive-
behavioral group therapy (CBT) for major depression in
hemodialysis (HD) patients. In this study group, receiving
CBT had signiﬁcant improvements, compared with the control
group, in the average scores on the Beck Depression Inventory
and Mini-International Psychiatric Interview, and in several
Kidney Disease Quality of Life-Short Form (KDQOL-SF)
dimensions up to 9 months. We would like to raise two issues.
The authors addressed most of the clinical characteristics that
could affect depression in HD patients, with the exception of
one: chronic pain. Chronic pain is a signiﬁcant problem for
B50% of HD patients. The impact of chronic pain on
Table 1 | Number of patients in CKD stage according to the
values of eGFR and Scr cut-off
eGFR (ml/min per 1.73m2) Scr (mg/dl)
CKD stage Cut-off No. (%) Cut-off No. (%)
1 X90 5156 (37.1) p0.7 5767 (41.5)
2 60–89 6990 (50.3) 0.8–1.0 6159 (44.3)
3 30–59 1360 (9.78) 1.1–1.6 1505 (10.8)
4 15–29 172 (1.24) 1.7–2.5 196 (1.41)
5 o15 227 (1.62) 42.5 278 (1.99)
13,905 (100) 13,905 (100)
Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration
rate; Scr, serum creatinine.
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